Market Overview:
The global clinical trial imaging market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing number of clinical trials, rising demand for better and faster diagnosis, and technological advancements in medical imaging equipment. The global clinical trial imaging market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into in-house imaging service and central Imaging service. In terms of application, the market is divided into pharmaceutical companies, biotechnology companies academic institutes others).
Product Definition:
clinical trial imaging: the use of medical images to help plan, monitor,.
In-house Imaging Service:
In-house imaging service is a research based technology that involves the usage of medical imaging devices within the organization. It can be defined as any diagnostic or therapeutic procedure carried out in an organizational setting other than hospitals and clinical facilities. The major factor responsible for its growth is cost efficiency, which helps organizations save huge amount of money by using their own equipment and professionals rather than outsourcing them to third party vendors.
Central Imaging Service:
Central imaging service is a comprehensive clinical trial imaging solution that includes all the equipment, software, and services required to perform image acquisition, management as well as analysis. It also includes reporting of results from single or multiple studies. Central imaging services are provided by companies like Siemens Healthineers along with other contract research organizations (CROs).
Application Insights:
The academic institutes segment held the largest share of the global market in 2017. This is attributed to presence of a large number of research organizations and universities across the globe. The pharmaceutical companies are anticipated to be the fastest-growing application segment over the forecast period owing to increasing R&D activities and investments by various companies for clinical trials.
For instance, in June 2018, Amgen launched a new investigational drug Taltz (ixekizumab) for plaque psoriasis (moderate-to-severe) based on phase 3 study results that showed positive outcomes for patients with moderate plaque psoriasis who were treated with ixekizumab 30 minutes once every two weeks compared with placebo. Such initiatives by key players are expected to fuel growth during future years.
Clinical trial imaging services play an important role in monitoring.
Regional Analysis:
North America accounted for the largest share in 2016 owing to the presence of major market players, well-established healthcare infrastructure and a large number of clinical trials. The region is expected to maintain its dominance during the forecast period due to continuous innovations in research techniques and high R&D investments by companies. Asia Pacific is anticipated to witness lucrative growth over the forecast period as a result of increasing government funding for medical & health research, rising patient pool suffering from chronic diseases, growing awareness about new treatment options & therapies, and an increase in disposable income. These factors are expected to drive regional market growth during the forecast period.
The key players operating in this industry are GlobalMed (U.S.), Celsus (U.S.
Growth Factors:
- Increasing incidence of chronic diseases and rising demand for better treatment options are the key growth drivers for Clinical Trial Imaging market.
- Growing number of clinical trials, increasing R&D expenditure by pharmaceutical and biotechnology companies, and technological advancements are also fuelling the growth of Clinical Trial Imaging market.
- Rising geriatric population is another major factor that is expected to drive the demand for Clinical Trial Imaging products in the coming years.
- Increasing awareness about benefits of early diagnosis and growing demand for minimally invasive diagnostic procedures are also propelling the growth of this market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trial Imaging Market Research Report
By Type
In-house Imaging Service, Central Imaging Service
By Application
Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others
By Companies
ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trial Imaging Market Report Segments:
The global Clinical Trial Imaging market is segmented on the basis of:
Types
In-house Imaging Service, Central Imaging Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ICON
- ERT
- McLaren
- Bioclinica
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
Highlights of The Clinical Trial Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In-house Imaging Service
- Central Imaging Service
- By Application:
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical trial imaging is the use of medical imaging techniques to study the effects of a treatment on patients. Imaging can be used to detect changes in tissue or organs, and can help doctors determine whether a patient is responding well to a treatment. Clinical trial imaging can also help researchers understand how treatments are working in individual patients.
Some of the major players in the clinical trial imaging market are ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., Intrinsic Imaging, Median Technologies, Cardiovascular Imaging Technologies, Banook Medical, IXICO.
The clinical trial imaging market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Imaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Trial Imaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Trial Imaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Trial Imaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Trial Imaging Market Size & Forecast, 2020-2028
4.5.1 Clinical Trial Imaging Market Size and Y-o-Y Growth
4.5.2 Clinical Trial Imaging Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 In-house Imaging Service
5.2.2 Central Imaging Service
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Biotechnology Companies
6.2.3 Academic Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Trial Imaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Trial Imaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 In-house Imaging Service
9.6.2 Central Imaging Service
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Biotechnology Companies
9.10.3 Academic Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 In-house Imaging Service
10.6.2 Central Imaging Service
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Biotechnology Companies
10.10.3 Academic Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 In-house Imaging Service
11.6.2 Central Imaging Service
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Biotechnology Companies
11.10.3 Academic Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 In-house Imaging Service
12.6.2 Central Imaging Service
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Biotechnology Companies
12.10.3 Academic Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 In-house Imaging Service
13.6.2 Central Imaging Service
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Biotechnology Companies
13.10.3 Academic Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Trial Imaging Market: Competitive Dashboard
14.2 Global Clinical Trial Imaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ICON
14.3.2 ERT
14.3.3 McLaren
14.3.4 Bioclinica
14.3.5 Parexel
14.3.6 BioTelemetry
14.3.7 ProScan Imaging
14.3.8 Imaging Endpoints
14.3.9 Radiant Sage
14.3.10 Micron, Inc.
14.3.11 Intrinsic Imaging
14.3.12 Median Technologies
14.3.13 Cardiovascular Imaging Technologies
14.3.14 Banook Medical
14.3.15 IXICO
